Download FREE Report Sample
Download Free sampleAgomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression.
Agomelatine Market contains market size and forecasts of Agomelatine in global, including the following market information:
Global Agomelatine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Agomelatine Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Agomelatine companies in 2021 (%)
The global Agomelatine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serotonin 2C Agonist Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Agomelatine include Servier, Rovi Pharma, Novartis, Nectid Inc and Jiangsu Haosen Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Agomelatine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Agomelatine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Agomelatine Market Segment Percentages, by Type, 2021 (%)
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Global Agomelatine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Agomelatine Market Segment Percentages, by Application, 2021 (%)
Depression
Obsessive Compulsive Disorder
Sleep Disorders
Generalized Anxiety Disorder
Multiple Sclerosis
Systemic Traumatic Pain
Autism
Other
Global Agomelatine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Agomelatine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Agomelatine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Agomelatine revenues share in global market, 2021 (%)
Key companies Agomelatine sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Agomelatine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Servier
Rovi Pharma
Novartis
Nectid Inc
Jiangsu Haosen Pharmaceutical Group
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
